Publications by authors named "Jacques Greiner"

Claim this Profile
I
In vivo characterization of dynein-driven nanovectors using Drosophila oocytes.
Nadège Parassol, Céline Bienvenu, Cécile Boglio, Sébastien Fiorucci, Delphine Cerezo, Jacques Greiner

PLoS One· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formulation of highly functionalizable DNA nanoparticles based on 1,2-dithiolane derivatives.
Coralie Charrat, Anaïs Biscotti, Guilhem Godeau, Jacques Greiner, Pierre Vierling

Chembiochem· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and in vitro biological evaluation of valine-containing prodrugs derived from clinically used HIV-protease inhibitors.
Dominique Roche, Jacques Greiner, Anne-Marie Aubertin, Pierre Vierling

Eur J Med Chem· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and in vitro biological evaluation of mannose-containing prodrugs derived from clinically used HIV-protease inhibitors with improved transepithelial transport.
Dominique Roche, Jacques Greiner, Anne-Marie Aubertin, Pierre Vierling

Bioconjug Chem· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and activity against Toxoplasma gondii, Plasmodium spp., and Mycobacterium tuberculosis of new 6-fluoroquinolones.
Guillaume Anquetin, Jacques Greiner, Nassira Mahmoudi, Maud Santillana-Hayat, Rafael Gozalbes

Eur J Med Chem· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quinolone-based drugs against Toxoplasma gondii and Plasmodium spp.
Guillaume Anquetin, Jacques Greiner, Pierre Vierling

Curr Drug Targets Infect Disord· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of oral bioavailability and brain distribution of the Ind(8)-Val conjugate of indinavir in rodents.
Manuela Pereira de Oliveira, Jean-Christophe Olivier, Claudine Pariat, Dominique Roche, Jacques Greiner

J Pharm Pharmacol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prodrugs of HIV protease inhibitors.
Pierre Vierling, Jacques Greiner

Curr Pharm Des· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prodrugs of HIV protease inhibitors-saquinavir, indinavir and nelfinavir-derived from diglycerides or amino acids: synthesis, stability and anti-HIV activity.
Bérangère Gaucher, Marielle Rouquayrol, Dominique Roche, Jacques Greiner, Anne-Marie Aubertin

Org Biomol Chem· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New bicyclam-GalCer analogue conjugates: synthesis and in vitro anti-HIV activity.
Jean-Michel Daoudi, Jacques Greiner, Anne-Marie Aubertin, Pierre Vierling

Bioorg Med Chem Lett· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transepithelial transport of prodrugs of the HIV protease inhibitors saquinavir, indinavir, and nelfinavir across Caco-2 cell monolayers.
Marielle Rouquayrol, Bérangère Gaucher, Dominique Roche, Jacques Greiner, Pierre Vierling

Pharm Res· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis